MacroGenics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.

About MGNX

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. 

CEO
Eric Risser
CEOEric Risser
Employees
341
Employees341
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2000
Founded2000
Employees
341
Employees341

MGNX Key Statistics

Market cap
105.55M
Market cap105.55M
Price-Earnings ratio
-2.51
Price-Earnings ratio-2.51
Dividend yield
Dividend yield
Average volume
446.69K
Average volume446.69K
High today
$1.67
High today$1.67
Low today
$1.51
Low today$1.51
Open price
$1.53
Open price$1.53
Volume
1.14M
Volume1.14M
52 Week high
$5.10
52 Week high$5.10
52 Week low
$0.9897
52 Week low$0.9897

MGNX News

TipRanks 16h
Director Makes Bold Move with Major MacroGenics Stock Purchase!

New insider activity at MacroGenics ( (MGNX) ) has taken place on August 21, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...

Analyst ratings

67%

of 6 ratings
Buy
33.3%
Hold
66.7%
Sell
0%

People also own

Based on the portfolios of people who own MGNX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.